Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 65219-566

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 65219-566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mitomycin-spl-structure (Mit07 0000 01)

Chemical structure of mitomycin showing its molecular framework with functional groups including amino, methoxy, and carbonyl moieties in a bicyclic system.*

FDA Label Image

Fresenius Kabi Logo (Mit07 0000 02)

FDA Label Image

Principal Display Panel – Mitomycin For Injection, Usp 5 mg/vial – Carton (Mit07 0000 03)

Packaging label for Mitomycin injection, USP 5 mg/vial, lyophilized powder for intravenous use. The label includes dosage information, warnings about intravenous administration and cytotoxicity, storage instructions, and manufacturing details by Fresenius Kabi USA, LLC, Lake Zurich, IL. The label also features barcodes and website information.*

FDA Label Image

Principal Display Panel – Mitomycin For Injection, Usp 5 mg/vial – Vial Label (Mit07 0000 04)

Label for Mitomycin injection, USP 5 mg/vial, a lyophilized powder for intravenous use. The label includes dosing and storage instructions, a caution that it is a cytotoxic agent, and notes it is manufactured for Fresenius Kabi USA, LLC. The vial is single-dose and contains mitomycin with mannitol to be reconstituted before use.*

FDA Label Image

Principal Display Panel – Mitomycin For Injection, Usp 20 mg/vial – Carton (Mit07 0000 05)

Mitomycin for Injection, USP 20 mg/vial powder label by Fresenius Kabi USA, LLC. The label features warnings about intravenous administration to avoid tissue damage and cautions it as a cytotoxic agent. Includes storage instructions and detailed preparation information for reconstitution with sterile water for injection.*

FDA Label Image

Principal Display Panel – Mitomycin For Injection, Usp 20 mg/vial – Vial Label (Mit07 0000 06)

Label for Mitomycin for Injection, USP 20 mg/vial, lyophilized powder for intravenous injection. The vial is a single-dose and labeled as a cytotoxic agent. Manufactured for Fresenius Kabi USA, LLC, made in India. Storage and dosage instructions are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.